Maggie James

969 total citations
25 papers, 721 citations indexed

About

Maggie James is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Maggie James has authored 25 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Maggie James's work include Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (5 papers) and Renal cell carcinoma treatment (4 papers). Maggie James is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (5 papers) and Renal cell carcinoma treatment (4 papers). Maggie James collaborates with scholars based in United States, United Kingdom and India. Maggie James's co-authors include Martin Gore, Tim Eisen, T. Ahmad, Richard Marais, Brian Schwartz, I. Gibbens, Lynn M. Schuchter, Keith T. Flaherty, Mark J. Ratain and Ronit Simantov and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Cardiology in Review.

In The Last Decade

Maggie James

14 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maggie James United States 8 568 412 115 103 99 25 721
T. Ahmad United Kingdom 7 566 1.0× 388 0.9× 66 0.6× 56 0.5× 87 0.9× 12 677
Rosalin Mishra United States 11 421 0.7× 345 0.8× 139 1.2× 81 0.8× 76 0.8× 20 724
I. Gibbens United Kingdom 6 489 0.9× 381 0.9× 88 0.8× 51 0.5× 62 0.6× 9 645
Andrew E. Aplin United States 15 604 1.1× 363 0.9× 75 0.7× 64 0.6× 106 1.1× 22 722
Mary Ellen Simcox United States 8 458 0.8× 351 0.9× 85 0.7× 102 1.0× 45 0.5× 12 643
Matthew Ulman United States 3 441 0.8× 416 1.0× 146 1.3× 148 1.4× 38 0.4× 3 702
Matthew Dankner Canada 12 390 0.7× 374 0.9× 222 1.9× 119 1.2× 90 0.9× 29 747
Yogindra Persaud United States 6 619 1.1× 368 0.9× 151 1.3× 99 1.0× 43 0.4× 12 818
Marian M. Deuker United States 6 580 1.0× 274 0.7× 65 0.6× 88 0.9× 56 0.6× 6 742
Chenjing Xia China 4 439 0.8× 308 0.7× 52 0.5× 49 0.5× 56 0.6× 9 538

Countries citing papers authored by Maggie James

Since Specialization
Citations

This map shows the geographic impact of Maggie James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie James more than expected).

Fields of papers citing papers by Maggie James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie James. The network helps show where Maggie James may publish in the future.

Co-authorship network of co-authors of Maggie James

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie James. A scholar is included among the top collaborators of Maggie James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie James. Maggie James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
James, Maggie, et al.. (2025). Inflammation-Driven Arrhythmias: Bridging Immunology and Electrophysiology. Cardiology in Review.
3.
4.
5.
James, Maggie, et al.. (2025). Artificial Intelligence in Cardiac Electrophysiology: Enhancing Mapping and Ablation Precision. Cardiology in Review. 3 indexed citations
6.
James, Maggie, et al.. (2025). CRISPR/Cas9-Based Gene Editing for Correcting Inherited Channelopathies. Cardiology in Review.
7.
8.
9.
10.
11.
12.
Abdullah, Tariq, et al.. (2023). Health Related Quality of Life among ESRD Patients on Hemodialysis and Kidney Transplant Recipients: A Comparative Study. European Journal of Medical and Health Sciences. 5(1). 44–48.
13.
James, Maggie, et al.. (2023). Peri-Renal Lymphangiomatosis: A Case Report Presenting a Rare Disease at a Rarer Location. Cureus. 1 indexed citations
14.
Eisen, Tim, Richard Marais, Annette Affolter, et al.. (2011). Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies. British Journal of Cancer. 105(3). 353–359. 33 indexed citations
15.
Larkin, James, Tom Ferguson, Lisa Pickering, et al.. (2010). A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma. British Journal of Cancer. 103(8). 1149–1153. 33 indexed citations
16.
Eisen, Tim, T. Ahmad, Keith T. Flaherty, et al.. (2006). Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. British Journal of Cancer. 95(5). 581–586. 483 indexed citations
17.
Eisen, Tim, T. Ahmad, M. Gore, et al.. (2005). Phase I trial of BAY 43–9006 (sorafenib) combined with dacarbazine (DTIC) in metastatic melanoma patients. Journal of Clinical Oncology. 23(16_suppl). 7508–7508. 41 indexed citations
18.
Waters, Justin S., L Pyle, Maggie James, et al.. (2004). Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma. British Journal of Cancer. 91(10). 1763–1768. 43 indexed citations
19.
Ahmad, T., Richard Marais, L Pyle, et al.. (2004). BAY 43-9006 in patients with advanced melanoma: The Royal Marsden experience. Journal of Clinical Oncology. 22(14_suppl). 7506–7506. 39 indexed citations
20.
James, Maggie & Karen Ward. (2001). Leading a multinational team of change agents at Glaxo Wellcome (now Glaxo SmithKline). Journal of Change Management. 2(2). 148–159. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Ahmad Breakdown of academic impact, for papers by Rosalin Mishra Breakdown of academic impact, for papers by I. Gibbens Breakdown of academic impact, for papers by Andrew E. Aplin Breakdown of academic impact, for papers by Mary Ellen Simcox Breakdown of academic impact, for papers by Matthew Ulman Breakdown of academic impact, for papers by Matthew Dankner Breakdown of academic impact, for papers by Yogindra Persaud Breakdown of academic impact, for papers by Marian M. Deuker Breakdown of academic impact, for papers by Chenjing Xia
Rankless by CCL
2026